Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13564
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBach, Leon Aen
dc.contributor.authorLeeding, K Sen
dc.contributor.authorLeng, S Len
dc.date.accessioned2015-05-16T03:26:37Z
dc.date.available2015-05-16T03:26:37Z
dc.date.issued1997-11-01en
dc.identifier.citationThe Journal of Endocrinology; 155(2): 225-32en
dc.identifier.govdoc9415056en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13564en
dc.description.abstractPC12 rat phaeochromocytoma cells are widely used as a model of neuronal differentiation. They express IGF receptors and are responsive to IGFs. The main IGF-binding protein synthesized by these cells is IGFBP-6. Glucocorticoids induce differentiation of PC12 cells towards a chromaffin phenotype. The effect of dexamethasone on IGFBP-6 levels was therefore studied. Dexamethasone (500 nM) decreased IGFBP-6 protein in conditioned media and mRNA levels to 61 +/- 5% (P < 0.0001) and 34 +/- 14% (P = 0.03) of control levels respectively. Incubation of PC12 cells with IGF-II (100 ng/ml) for 72 h increased IGFBP-6 protein levels in media to 217 +/- 19% of control (P < 0.0001). IGFBP-6 mRNA levels, however, were unchanged. IGF-I had similar effects on IGFBP-6 protein and mRNA levels. IGFs increased cell number by 50-60%, but this was insufficient to explain the increases in protein levels. IGFBP-6 was not released from a cell-associated reservoir or protected from proteolysis by IGFs, excluding these post-translational mechanisms as explanations for the IGF effects on IGFBP-6 levels. The effects of IGF-II and dexamethasone on IGFBP-6 levels were independent. These results indicated that (1) dexamethasone decrease IGFBP-6 at the mRNA level, and (2) IGFs stimulate IGFBP-6 levels by a post-transcriptional mechanism.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherBlotting, Westernen
dc.subject.otherCell Counten
dc.subject.otherCell Differentiation.drug effectsen
dc.subject.otherDexamethasone.pharmacologyen
dc.subject.otherGlucocorticoids.pharmacologyen
dc.subject.otherInsulin-Like Growth Factor Binding Protein 6.genetics.metabolismen
dc.subject.otherInsulin-Like Growth Factor I.pharmacologyen
dc.subject.otherInsulin-Like Growth Factor II.pharmacologyen
dc.subject.otherPC12 Cells.drug effects.metabolismen
dc.subject.otherRNA, Messenger.analysisen
dc.subject.otherRatsen
dc.subject.otherSomatomedins.pharmacologyen
dc.titleRegulation of IGF-binding protein-6 by dexamethasone and IGFs in PC12 rat phaeochromocytoma cells.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of Endocrinologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin, Australiaen
dc.description.pages225-32en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/9415056en
dc.type.austinJournal Articleen
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Dec 20, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.